Piezoelectric cold atmospheric plasma modulates neurogenic cell proliferation and differentiation via cross-signaling

Cold atmospheric plasma (CAP), an ionized gas produced at near-room temperature, holds significant therapeutic potential due to its unique composition of reactive oxygen and nitrogen species (RONS). CAP exhibits selective bioactivity, targeting malignant cells while promoting healthy tissue regeneration, making it relevant for oncology and tissue engineering. Although Piezo-CAP has shown promise in ameliorating spinal cord injury (SCI) by reducing ROS and suppressing apoptosis, the precise molecular mechanisms governing its effects on neurogenesis and cellular fate remain largely unelucidated, representing a critical knowledge gap this study addresses.

This study investigated the impact of piezoelectric cold atmospheric plasma (Piezo-CAP) on neurogenic cell proliferation and differentiation. While the abstract does not specify the exact model (e.g., in vitro cell line, animal model) or the precise treatment parameters (e.g., dose, frequency, duration of plasma exposure), the research aimed to elucidate the underlying molecular mechanisms. The focus was on how Piezo-CAP's unique composition of reactive oxygen and nitrogen species (RONS) influences cross-signaling pathways to modulate cellular fate. The primary endpoint was the modulation of neurogenic cell proliferation and differentiation.

The study demonstrated that Piezo-CAP effectively modulates both neurogenic cell proliferation and differentiation. While specific quantitative data, such as percentages of change or fold-increases in differentiation markers, were not provided in the abstract, the findings indicate that this modulation occurs via cross-signaling pathways. The therapeutic effects of CAP are attributed to its unique composition of reactive oxygen and nitrogen species (RONS), which are known to interact with various cellular processes. > This research suggests that Piezo-CAP's ability to remodel the extracellular matrix and stimulate growth factor secretion, as mentioned in the introduction, plays a role in its neurogenic effects. The abstract also referenced previous work showing Piezo-CAP ameliorates spinal cord injury (SCI) by reducing reactive oxygen species (ROS), suppressing apoptosis, and promoting axonal regeneration through antioxidative mechanisms, providing context for the current study's focus on neurogenesis.